Close Menu

Nobel laureate Elizabeth Blackburn has launched a company called Telome Health, and has created a commercial genetic test to measure telomere shortening, to give people insight on their aging process, reports Boonsri Dickinson at New Scientist. Blackburn says telomere length can give a patient a "sense of your underlying health," as researchers see telomere shortening in conditions like heart disease and cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.